Mirati Therapeutics, Inc.

Historical 13F Holders

Symbol
MRTX
CUSIP
60468T105
All holders as of
Q1 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 2 43.0 $2.53 k
2023 Q4 256 85.6 M $5.02 B
2023 Q3 237 81.0 M $3.53 B
2023 Q2 231 65.9 M $2.38 B
2023 Q1 240 64.1 M $2.38 B
2022 Q4 266 68.0 M $3.08 B
2022 Q3 276 64.3 M $4.49 B
2022 Q2 264 62.8 M $4.22 B
2022 Q1 275 57.5 M $4.72 B
2021 Q4 292 60.2 M $8.83 B
2021 Q3 278 54.2 M $9.59 B
2021 Q2 269 56.3 M $9.09 B
2021 Q1 289 56.9 M $9.75 B
2020 Q4 324 53.0 M $11.6 B
2020 Q3 257 48.2 M $8.00 B
2020 Q2 230 48.6 M $5.55 B
2020 Q1 211 49.0 M $3.77 B
2019 Q4 230 43.2 M $5.57 B
2019 Q3 212 43.4 M $3.38 B
2019 Q2 212 44.2 M $4.55 B
2019 Q1 184 40.4 M $2.96 B
2018 Q4 125 35.8 M $1.52 B
2018 Q3 148 34.2 M $1.61 B
2018 Q2 122 31.8 M $1.57 B
2018 Q1 87 24.8 M $761 M
2017 Q4 67 22.4 M $408 M
2017 Q3 54 17.5 M $204 M
2017 Q2 53 15.0 M $54.8 M
2017 Q1 69 16.2 M $84.3 M
2016 Q4 65 12.0 M $56.8 M
2016 Q3 71 12.2 M $80.7 M
2016 Q2 74 13.9 M $75.9 M
2016 Q1 68 16.4 M $352 M
2015 Q4 85 15.8 M $499 M
2015 Q3 82 13.9 M $479 M
2015 Q2 68 11.0 M $347 M
2015 Q1 58 10.9 M $319 M
2014 Q4 44 8.14 M $150 M
2014 Q3 44 8.04 M $140 M
2014 Q2 46 8.34 M $167 M
2014 Q1 33 9.04 M $172 M